Kaye Alan D, Stout Tyler B, Padnos Ira W, Schwartz Brian G, Baluch Amir R, Fox Charles J, Liu Henry
Department of Anesthesiology, Louisiana State University Health Sciences Center, Louisiana State University School of Medicine, 1542 Tulane Ave, Room 656, New Orleans, LA 70112, USA.
Middle East J Anaesthesiol. 2012 Oct;21(6):793-806.
Congenital heart disease (CHD) affects roughly 8/1000 live births. Improvements in medical and surgical management in recent decades have resulted in significantly more children with left-to-right cardiac shunts surviving into adulthood. Surgical care of these patients for their original cardiac defect(s) or other non-cardiac medical conditions requires thorough understanding of cardiopulmonary changes and mastery of treatment options. Commonly encountered CHD with left-to-right shunt include atrial septal defect (ASD), ventricular septal defect (VSD), endocardial cushion defect (ECD) and patent ductus arteriosus (PDA). The key pathological change is increased pulmonary vascular resistance (PVR) and pressure secondary to increased blood flow from the left-to-right shunt. Increasing PVR and pulmonary arterial hypertension (PAH) will lead to reversed direction of blood flow through the cardiac defect (Eisenmenger Syndrome) and heart failure. Cardiac defects with left-to-right shunt generally require surgical or trans-catheter repair at an early age. We review the current concepts and general principles of perioperative anesthetic management of CHD, including neuraxial anesthesia. Current techniques and unique pharmacodynamic and pharmacokinetic effects of some commonly used anesthetic agents in patients with left-to-right shunt are also reviewed.
先天性心脏病(CHD)的发病率约为每1000例活产中有8例。近几十年来,医学和外科治疗的进步使更多患有左向右心脏分流的儿童存活至成年。对这些患者进行原发性心脏缺陷或其他非心脏疾病的外科治疗需要全面了解心肺变化并掌握治疗方案。常见的伴有左向右分流的先天性心脏病包括房间隔缺损(ASD)、室间隔缺损(VSD)、心内膜垫缺损(ECD)和动脉导管未闭(PDA)。关键的病理变化是由于左向右分流导致血流量增加,从而引起肺血管阻力(PVR)和压力升高。PVR增加和肺动脉高压(PAH)将导致心脏缺损处血流方向逆转(艾森曼格综合征)和心力衰竭。伴有左向右分流的心脏缺损通常需要在早期进行手术或经导管修复。我们回顾了先天性心脏病围手术期麻醉管理的当前概念和一般原则,包括神经轴麻醉。还回顾了一些常用麻醉剂在左向右分流患者中的当前技术以及独特的药效学和药代动力学效应。